Post-approval studies (Phase 4)Study completedNCT01185938What this trial is testingStatin Contrast Induced Nephropathy PreventionWho this might be right forAcute Coronary Syndrome Centro Cardiopatici Toscani 500
Not applicableStudy completedNCT06878638What this trial is testingNitrate - Clopidogrel - Acute Coronary SyndromeWho this might be right forAcute Coronary Syndromes Bursa Postgraduate Hospital 20
Not applicableStudy completedNCT01231035What this trial is testingREsponsiveness to CLOpidogrel and Stent-related Events in Acute Coronary Syndromes (RECLOSE 2 - ACS)Who this might be right forAcute Cardiac SyndromeStent ThrombosisPlatelet Function+1 more Careggi Hospital 1,789
Testing effectiveness (Phase 2)Looking for participantsNCT06254391What this trial is testingAspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary SyndromeWho this might be right forMyocardial InfarctionAcute Coronary Syndrome Medical University of Warsaw 40
Post-approval studies (Phase 4)Study completedNCT04418479What this trial is testingSMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3Who this might be right forCoronary Artery Disease Joo-Yong Hahn 5,506
Large-scale testing (Phase 3)Not Yet RecruitingNCT07164859What this trial is testingSafety and Efficacy of Very Short DAPT in Older Patients Undergoing PCIWho this might be right forCoronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)Antiplatelet Therapy+1 more Vincent ROULE 1,700
Not applicableStudy completedNCT03197298What this trial is testingChange of Dual Antiplatelet Therapy in Patients With Acute Coronary SyndromeWho this might be right forAcute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting Stents Thorax Centrum Twente 2,062
Testing effectiveness (Phase 2)Study completedNCT04824911What this trial is testingStatin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous DiseaseWho this might be right forAcute StrokeDual Antiplatelet TherapyStatin Chang Gung Memorial Hospital 376
Post-approval studies (Phase 4)Looking for participantsNCT05681702What this trial is testingTailoring Bleeding Reduction Approaches in Patients Undergoing PCIWho this might be right forCoronary Artery Disease University of Florida 90
Not applicableEnded earlyNCT02030548What this trial is testingBleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet TherapyWho this might be right forAcute Coronary Syndrome Medical University of Graz 144
Not applicableLooking for participantsNCT06412250What this trial is testingObservational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)Who this might be right forCardiovascular Diseases Translumina Therapeutics Pvt Ltd. 2,000
Post-approval studies (Phase 4)Study completedNCT00190307What this trial is testingSTRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary SurgeryWho this might be right forThrombosis Assistance Publique - Hôpitaux de Paris 293
Testing effectiveness (Phase 2)Study completedNCT01442792What this trial is testingExploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary InterventionWho this might be right forCardiovascular DiseaseCoronary Artery Disease Bayer 108
Post-approval studies (Phase 4)Looking for participantsNCT05995600What this trial is testingComparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKEWho this might be right forAntiphospholipid SyndromeIschemic StrokeTransient Ischemic Attack+3 more Seoul National University Hospital 200
Not applicableStudy completedNCT06881901What this trial is testingAntiplatelet Strategy for CCS Patients Undergoing CABGWho this might be right forChronic Coronary SyndromeCoronary Artery Bypass Graft CABG Samsung Medical Center 29,898
Post-approval studies (Phase 4)UnknownNCT04116931What this trial is testingOPTImal Management of Antithrombotic Agents: OPTIMA-5Who this might be right forAcute Coronary Syndrome (ACS) The First Affiliated Hospital with Nanjing Medical University 80
Not applicableLooking for participantsNCT06620757What this trial is testingSafety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world RegistryWho this might be right forAtrial Fibrillation Fundación EPIC 234
Testing effectiveness (Phase 2)UnknownNCT02492230What this trial is testingLeft Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCIWho this might be right forMyocardial Infarction Meshalkin Research Institute of Pathology of Circulation 50
Post-approval studies (Phase 4)Looking for participantsNCT07025148What this trial is testingDual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)Who this might be right forCoronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI) University of Florida 40
Post-approval studies (Phase 4)Study completedNCT01145079What this trial is testingA New Strategy Regarding Discontinuation of Dual AntiplateletWho this might be right forCoronary Artery Disease Yonsei University 982